Evidence-Based Dermatology

Description

Evidence-based Dermatology, Second Edition is a unique book in the field of clinical dermatology. Written and edited by some of the world's leading experts in evidence-based dermatology, it takes a highly evidence-based approach to the treatment of all major and many of the less common skin conditions.

The toolbox at the beginning of the book explaining how to critically appraise different studies, along with the comprehensive reviewing and appraisal of evidence in the clinical chapters makes this book distinctive in its field as do the treatment recommendations which are based on the discussion of the best available evidence using a question-driven approach and a common structure on dealing with efficacy, drawbacks and implications for clinical practice.

Table of Contents

Part I: The concept of evidence-based dermatology, Andrew Herxheimer, Editor

1. The field and its boundaries
2. The rationale for evidence-based dermatology
3. The role of the consumer and the public in evidence-based dermatology
4. The Cochrane Skin Group

Part II: The critical appraisal toolbox, Michael Bigby, Editor

5. Formulating well-built clinical questions
6. Finding the best evidence
7. The hierarchy of evidence
8. Appraising systematic reviews and meta-analyses
9. How to critically appraise a randomized controlled trial
10. How to assess the evidence concerning the safety of medical interventions
11. What makes a good case series?
12. What makes a good prevalence survey?
13. Critical appraisal of pharmacoeconomic studies
14. Applying the evidence back to the patient

Part III: The evidence

Part IIIa: Common inflammatory skin diseases, Luigi Naldi, Editor

15. Acne vulgaris
16. Papulopustular rosacea
17. Perioral dermatitis
18. Hand eczema
19. Atopic eczema
20. Seborrheic dermatitis
21. Psoriasis
22. Lichen planus
23. Acute urticaria
24. Chronic urticaria

Part IIIb: Skin cancer, moles, and photoaging, Hywel Williams, Editor

25. Primary prevention of skin cancer
26. Do sunscreens reduce the incidence of skin cancers?
27. Cutaneous melanoma
28. Squamous cell carcinoma
29. Basal cell carcinoma
30. Primary cutaneous T-cell lymphoma
31. Actinic keratoses and Bowen's disease
32. Kaposi's sarcoma
33. Photoaging
34. Melanocytic nevi

Part IIIc: Infective skin diseases and exanthema, Hywel Williams and Thomas Diepgen, Editors

35. Local treatment for cutaneous warts
36. Impetigo
37. Athlete's foot
38. Onychomycosis
39. Tinea capitis
40. Deep fungal infections
41. Streptococcal cellulitis/erysipelas of the lower leg
42. Exanthematic reactions
43. Herpes simplex
44. Leprosy
45. Cutaneous leishmaniasis

Part IIId: Infestations, Berthold Rzany, Editor

46. Scabies
47. Head lice
48. Insect bites and stings

Part IIIe: Disorders of pigmentation, Berthold Rzany, Editor

49. Vitiligo
50. Melasma

Part IIIf: Hair problems, Berthold Rzany, Editor

51. Male and female androgenetic alopecia
52. Alopecia areata
53. Evidence-based treatment of hirsutism

Part IIIg: Leg ulceration, Berthold Rzany, Editor

54. Venous ulcers

Part IIIh: Other important skin disorders

55. Cutaneous lupus erythematosus
56. Dermatomyositis
57. Acquired subepidermal bullous diseases
58. Pemphigus
59. Cutaneous sarcoidosis
60. Erythema multiforme
61. Stevens-Johnson syndrome and toxic epidermal necrolysis
62. Focal hyperhidrosis
63. Polymorphic light eruption (PLE)
64. Infantile hemangiomas and port-wine stains
65. Psychocutaneous disease
66. Pruritus
67. Other skin diseases for which trials exist

Part IV: The future of evidence-based dermatology, Luigi Naldi, Editor

68. Where do we go from here?, Hywel Williams

About the Author

Hywel Williams
Professor of Dermato-Epidemiology, Nottingham UK. Professor Williams is coordinating editor of the Cochrane Skin Group. He is also the dermatology adviser for Clinical Evidence (BMJ Publishing Group) which is distributed to 500 000 doctors in the US, available free to NHS institutions in the UK and is translated into 10 languages.

Michael Bigby
Assistant Professor of Dermatology, Harvard University Medical School and Chief of Dermatology, Harvard University Health Service. His chief teaching interest is in evidence-based dermatology. He edited a special issue of the Archives in Dermatology devoted to ebd, which has resulted in a quarterly ebd section to which he is a continuing contributor, and he has presented papers and chaired sessions on ebd at the AAD. He has played a major part in introducing the concept in the USA.

Thomas Diepgen
Professor of Dematology, University of Heidelberg, Gemany is a member of European Dermato-epidemiology network and a specialist in contact dermatitis, and occupationally and environmentally acquired conditions

Andrew Herxheimer
Cochrane UK Center is a founding member of the Cochrane Collaboration and now a editor of the Consumer and Communications Group. He is part of the Consumer Network and the Adverse Effects Methods subgroup and also works with the Cochrane skin group.

Luigi Naldi
Consultant Dermatologist at Ospedale Riunit Bergamo, Italy and a member of European Dermato-epidemiology network. He specialises in psoriasis.

Berthold Rzany
C3-Professor for Evidence Based Medicine in Dermatology, Head of the division of Evidence Based Medicine at the department of dermatology at the Humboldt-University in Berlin. His research topics include aesthetic medicine, e.g. botulinum toxin A, collagen, hyaluronic acid, polyactic acid & other injectables, middle depth peelings as well as hyperhidrosis.